Skip to content

Advertisement

BMC Complementary and Alternative Medicine

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

The ethanol extract of Aquilariae Lignum ameliorates hippocampal oxidative stress in a repeated restraint stress mouse model

  • Hyun-Yong Lee1,
  • Jin-Seok Lee2,
  • Hyeong-Geug Kim2,
  • Won-Yong Kim2,
  • Seung-Bae Lee2,
  • Yung-Hyun Choi3 and
  • Chang-Gue Son2Email author
Contributed equally
BMC Complementary and Alternative MedicineBMC series – open, inclusive and trusted201717:397

https://doi.org/10.1186/s12906-017-1902-1

Received: 9 January 2017

Accepted: 2 August 2017

Published: 10 August 2017

Abstract

Background

Chronic stress contributes to the development of brain disorders, such as neurodegenerative and psychiatric diseases. Oxidative damage is well known as a causative factor for pathogenic process in brain tissues. The aim of this study is to evaluate the neuroprotective effect of a 30% ethanol extract of Aquilariae Lignum (ALE) in repeated stress-induced hippocampal oxidative injury.

Methods

Fifty BALB/c male mice (12 weeks old) were randomly divided into five groups (n = 10). For 11 consecutive days, each group was orally administered with distilled water, ALE (20 or 80 mg/kg) or N-acetylcysteine (NAC; 100 mg/kg), and then all mice (except unstressed group) were subjected to restraint stress for 6 h. On the final day, brain tissues and sera were isolated, and stress hormones and hippocampal oxidative alterations were examined. We also treated lipopolysaccharide (LPS, 1 μg/mL)-stimulated BV2 microglial cells with ALE (1 and 5 μg/mL) or NAC (10 μM) to investigate the pharmacological mechanism.

Results

Restraint stress considerably increased the serum levels of corticosterone and adrenaline and the hippocampal levels of reactive oxygen species (ROS), nitric oxide (NO), and malondialdehyde (MDA). ALE administration significantly attenuated the above abnormalities. ALE also significantly normalized the stress-induced activation of astrocytes and microglial cells in the hippocampus as well as the elevation of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β). The in vitro assay outcome supplemented ALE could dramatically block NF-κB activation in microglia. The anti-oxidative stress effects of ALE were supported by the results of antioxidant components, 4-hydroxynonenal (4-HNE), NADPH oxidase 2 (NOX2), inducible nitric oxide synthase (iNOS) and NFE2L2 (Nrf2) in the hippocampal tissues.

Conclusions

We firstly demonstrated the neuroprotective potentials of A. Lignum against hippocampal oxidative injury in repeated restraint stress. The corresponding mechanisms might involve modulations in the release of ROS, pro-inflammatory cytokines and stress hormones.

Keywords

Repeated restraint stressBrain oxidative stressHippocampusMicroglia Aquilariae lignum

Background

Stress is generally defined as a homeostatic disruption from actual or implied threats [1]. After the recognition of stressors, the brain mediates integrative stress-coping responses via the hypothalamic-pituitary-adrenal (HPA) axis, which accompanies the release of stress hormones, including glucocorticoids and catecholamines [2]. Under chronic stress, these stress hormones are significantly elevated, affecting the development or progress of mental and physical disorders, such as neurodegenerative, cardiovascular, and cancerous diseases [35].

Brain tissue is a main target of stress, which is somewhat related to oxidative injury [6, 7]. A few studies have revealed that chronic stress can increase the production of free radicals in the brain via the activation of NADPH oxidase (NOX) [8, 9]. The brain is prone to oxidative stress due to its large consumption of oxygen [10], low levels of antioxidants [11], and high contents of iron and polyunsaturated fatty acids [12]. In particular, the hippocampus contains high levels of glucocorticoid receptors and thus, is vulnerable to excessive glucocorticoid exposure or chronic stress [13, 14]. Stress-induced hippocampal oxidative injury is known to be closely related with cognitive impairment and emotional distress [15, 16].

Herbs have gained increased prominence as pharmaceutical agents for preventing brain oxidative stress or neurodegenerative disorders [1719]. Aquilariae Lignum (沉香), also called agarwood, and its rich aromatic compounds have been used in Southeast and East Asian regions for soothing anxiety, pain or inflammation [20, 21]. Recent studies have shown anti-oxidative, anti-inflammatory, and neuroleptic capacities of A. Lignum [2224]. Furthermore, its molecular derivative is known to relieve neuropsychiatric symptoms via modulating central monoamine neurotransmitters in several brain regions [25]. In our preliminary in vitro study, A. Lignum extracts significantly protected HT22 hippocampal neuronal cell line from glutamate excitotoxicity, which implies its neuropharmacologial action in stress-related brain disorders.

Therefore, we hypothesized that A. Lignum could be a potential candidate against stress-related brain oxidative injury. The current study used a repeated restraint stress mice model to investigate the effects of A. Lignum on oxidative distortions, particularly in the hippocampal region, and a supplementary in vitro assay using BV2 murine microglial cell line to explore the pharmacological mechanism.

Methods

Preparation of Aquilariae lignum

Aquilariae Lignum of the Aquilariae malaccensis species was obtained from an herbal pharmaceutical company (Dae Han Bio Pharm Inc., Gyeonggi-do, Korea). An ethanol extract of A. Lignum (ALE) was prepared as follows: 10 g of dried A. Lignum was pulverized with a grinder and mixed with 100 mL of 30% ethanol on a moving shaker (150 rpm) for 72 h at room temperature (RT). After centrifuging the suspension, the supernatant was collected and filtered through a 300-mesh, 50-nm filter paper (Advantec, Tokyo, Japan). The filtrate was concentrated in a rotary evaporator and lyophilized. The final extraction yield was 6.42% (w/w). The extract was dissolved in distilled water before use and the remainder was stored at −80 °C for future use.

Fingerprinting analysis of ALE

We conducted ultra-high-performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS) on ALE to determine its reproducibility and chemical composition. Briefly, a 5-mg aliquot of ALE was dissolved in 1 mL of 90% methanol, and the solution was filtered (0.45-μm). Then, the ALE sample was subjected to UHPLC–MS using an LTQ Orbitrap XL linear ion-trap MS system (Thermo Scientific Co., San Jose, CA, USA) equipped with an electrospray ionization source. Separation was performed on an Accela UHPLC system using an Acquity BEH C18 column (1.7 μm, 2.1 × 150 mm; Waters, Milford, MA, USA). The mobile phase conditions were prepared as follows: (A) was distilled water and (B) was acetonitrile, both of which contained 0.1% formic acid. The column was eluted at a flow rate of 0.4 mL/min with the following gradients: 0 to 1 min, 5% B (isocratic); 1 to 20 min, 5 to 70% B (linear gradient); 20 to 24 min, 70 to 100% B (linear gradient); and 24 to 27 min, 100% B (isocratic). ALE was detected using a photodiode array at 200–700 nm. The full-scan mass spectra were acquired at 150–1500 m/z in positive ion mode. The Orbitrap analyzer was used for high-resolution mass data acquisition with a mass resolving power of 30,000 FWHM at 400 m/z. Tandem mass (MS/MS) spectra were acquired in data-dependent mode by collision-induced dissociation.

Reagents and chemicals

The following reagents were obtained from Sigma (St. Louis, MO, USA): 4-amino-3-hydrazino-5-mercapto-1,2,4-triazole (Purpald), 1-chloro-2,4-dinitrobenzene (CDNB), N,N-diethyl-p-phenylenediamine (DEPPD), 5,5-dithio-bis-2-nitrobenzoic acid (DTNB), ferrous sulfate, potassium phosphate, reduced glutathione (GSH), glutathione reductase (GSH-Rd), L-glutathione oxidized disodium salt (GSSG), β-nicotinamide adenine dinucleotide phosphate-reduced form (β-NADPH), and 1,1,3,3-tetraethoxypropane (TEP). Other reagents were obtained from the following manufacturers: anti-4-hydroxynonenal (4-HNE), NADPH oxidase 2 (NOX2), inducible nitric oxide synthase (iNOS), NF-E2-related factor 2 (Nrf2), NF-kappa B p65 (NF-κB p65), β-actin and Lamin B1 antibodies, and horseradish peroxidase (HRP)-conjugated horseradish peroxidase secondary antibody for western blotting (Abcam, Cambridge, MA; Thermo Scientific; and Santa Cruz Biotechnology, Santa Cruz, CA, USA), NE-PER® Nuclear and Cytoplasmic Extraction Reagents for separating cytoplasmic and nuclear proteins (Thermo scientific), anti-glial fibrillary acidic protein (GFAP) and ionized calcium-binding adapter molecule 1 (Iba1) antibodies, and a biotinylated goat anti-rabbit secondary antibody for immunohistochemical staining (Dako, Hamburg, Germany; Wako, Osaka, Japan; Vector Lab., Burlingame, CA, USA), Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), penicillin, streptomycin and trypsin-ethylenediaminetetra acetic acid (EDTA) solution for cell cultures and in-vitro experiments (Welgene, Gyeongsangbuk-do, Korea), Triton X-100, 4′,6-diamidino-2-phenylindole (DAPI) and a goat anti-rabbit Alexa Fluor® 488-conjugated secondary antibody for cellular immunofluorescent staining (Amresco LLC, Solon, OH, USA; Sigma; Abcam), Bovine serum albumin (GenDEPOT, Barker, TX, U.S.A), thiobarbituric acid (TBA; Lancaster Co., Lancashire, England), H2O2, (Junsei Chemical Co., Ltd., Tokyo, Japan), n-butanol (J.T. Baker, Mexico City, Mexico), a 1 M Tris-HCl solution (pH 7.4) and a 500 mM ethylene diaminetetraacetic acid (EDTA) solution (pH 8.0; Bioneer, Daejeon, Republic of Korea).

Animals and experimental design

Fifty specific pathogen-free BALB/c male mice (12 weeks old; 26–28 g) were purchased from Dae Han Bio Pharm Inc. They were housed in a room maintained at 23 ± 2 °C with a 12 h light-dark cycle and fed with food (Cargill Agri Purina, Gyeonggido, Korea) and water ad libitum. After acclimation for 1 week, the mice were randomly divided into five groups (n = 10): unstressed, control, ALE (20 or 80 mg/kg), and N-acetylcysteine (NAC) groups (100 mg/kg, as a positive control). Each group was orally administered with distilled water (unstressed and control group), ALE or NAC every 11 days. One hour after the oral administration, all mice except those in the unstressed group were subjected to restraint stress through confinement inside 50-mL conical tubes (with 0.5 cm air holes for breathing) for 6 h without access to food or water, according to a previous study [26]. The restraint stress model was conducted from 11:00 to 17:00 daily.

The ALE dosage was based on prescreening results of in vitro assays and clinical experiences. The protocol was approved by the Institutional Animal Care and Use Committee (IACUC) of Daejeon University (DJUARB2016–029) and was conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the United States National Institutes of Health (NIH).

Preparation of brain tissues and sera

Upon the end of the final restraint stress, the mice were immediately sacrificed under ether anesthesia. Blood and brains were collected following IACUC criteria. Then, the blood was centrifuged at 3000×g for 15 min at 4 °C to separate the sera. Three brains from each group were fixed in 4% paraformaldehyde solution for immunohistochemical staining. The hippocampal regions were isolated from the remaining seven brains of each group. Then, the hippocampal regions were homogenized in radioimmunoprecipitation assay (RIPA) buffer for biochemical analysis and western blotting or in 1.15% KCl for malondialdehyde (MDA) formation assays. The hippocampus homogenates and sera were stored at −80 °C. Protein concentrations of the hippocampus were determined using a Bicinchoninic Acid Protein Assay kit (Sigma).

Determination of corticosterone and adrenaline

Serum corticosterone levels were measured using commercially available enzyme immunoassay (EIA) kits (Corticosterone EIA Kit, Arbor Assays, Ann Arbor, MI, USA). Serum adrenaline levels were determined using a commercial kit (Adrenaline Research ELISA, LDN, Nordhorn, Germany). Absorbances were measured at 450 and 570 nm using a UV spectrophotometer (Molecular Devices, Sunnyvale, CA, USA).

Determination of reactive oxygen species (ROS) and nitric oxide (NO) levels

Total ROS levels in the hippocampus and serum were determined as previously described [27]. Briefly, the hippocampal homogenates and sera were prepared with sodium acetate buffer (0.1 M, pH 4.8). After incubation at 37 °C for 5 min, a DEPPD (10 mM)/ferrous sulfate solution (4.37 μM) mixture (1:25) was added. Absorbance was measured at 505 nm using a UV spectrophotometer, and the results were calculated using an H2O2 standard curve.

The hippocampal NO level was measured using the Griess reagent method [28]. The hippocampal homogenates were mixed with Griess reagent (1% sulfanilamide, 0.1% N-(1-naphthyl) ethylenediamine hydrochloride, and 2.5% phosphoric acid). After incubating at 37 °C for 20 min, the product absorbance was measured at 540 nm using a UV spectrophotometer.

Determination of malondialdehyde (MDA) level

The hippocampal MDA level was determined using the thiobarbituric acid reactive substance (TBARS) method [29]. The hippocampal tissues were homogenized on ice-cold 1.15% KCl buffer. The homogenates were mixed with 1% phosphoric acid and 0.67% of thiobarbituric acid (TBA). After incubating at 100 °C for 45 min, the mixtures were placed on ice for 5 min and n-butanol was added. The homogenates were centrifuged at 3000×g for 15 min at 4 °C, and absorbances at 535 and 520 nm were measured using a UV spectrophotometer. The concentration of TBARS was calculated using a TEP standard curve.

Immunohistochemical staining analysis

Immunohistochemical analyses were performed to assess the activations of microglial cells and astrocytes with ionized calcium-binding adapter molecule 1 (Iba1) and glial fibrillary acidic protein (GFAP) in the hippocampus. After immersing in a fixative solution for 4 h, the brain tissues were cryoprotected for 24 h in 10, 20, and 30% sucrose, alternately. Then, the tissues were embedded in tissue-freezing medium with liquid nitrogen and cut into coronal frozen sections (35-μm) using a Leica CM3050 cryostat (Leica Biosystems, Buffalo Grove, IL, USA). The sections were stored in the anti-freeze buffer.

Free-floating sections were subjected to endogenous peroxidase quenching with 1% H2O2 in phosphate-buffered saline (PBS), followed by treatment with blocking buffer (5% normal chicken serum and 0.3% Triton X-100 in PBS) for 1 h. Then, the sections were incubated with Iba1 (1:200, 019–19,741, Wako) or GFAP (1:200, Z0334, Dako) antibodies overnight at 4 °C. After washing four times with PBS, the sections were subjected to a biotinylated goat anti-rabbit (1:400, BA-1000, Vector Lab.) secondary antibody for 2 h and exposed to an avidin-biotin peroxidase complex (ABC; PK-4001, VECTASTAIN ABC HRP Kit, Vector Lab.) for 1 h. The peroxidase activity was visualized using stable 3,3′-diaminobenzidine (DAB; D5637-1G, Sigma) and 3-amino-9-ethylcarbazole (AEC; SK-4200, Vector Lab.). All immunoreactions were observed using an Axio-phot microscope (Carl Zeiss, Oberkochen, Germany) and the results were quantified using ImageJ version 1.46 (NIH, Bethesda, MD, USA).

Determination of tumor necrosis factor (TNF)-α and interleukin (IL)-1β levels

Hippocampal TNF-α levels were determined using a commercially available EIA kit (Mouse TNF ELISA Set II, BD Biosciences, San Diego, CA, USA). Hippocampal IL-1β levels were also measured using a commercial kit (Mouse IL-1β/IL-1F2 Duoset ELISA, R&D Systems, Minneapolis, MN, USA). Absorbances at 450 and 570 nm were measured using a UV spectrophotometer.

Western blot analysis

Hippocampal expressions of 4-hydroxynonenal (4-HNE)-modified protein, NADPH oxidase 2 (NOX2), inducible nitric oxide synthase (iNOS), NFE2L2 (Nrf2) and β-actin proteins were analyzed by western blot. The proteins from homogenates were separated by 10% polyacrylamide gel electrophoresis and transferred to polyvinylidene fluoride (PVDF) membranes. After blocking in 5% skim milk for 1 h, the membranes were probed overnight at 4 °C with primary antibodies (4-HNE, NOX2, iNOS, Nrf2 and β-actin). Then, the samples were washed three times and incubated for 2 h with HRP-conjugated anti-rabbit or anti-mouse antibody. Western blots were visualized using an enhanced chemiluminescence (ECL) advanced kit. The protein expression was semi-quantified using ImageJ (NIH).

Determination of superoxide dismutase (SOD) and catalase

Hippocampal SOD activity was determined using an SOD assay kit (Dojindo Laboratories; Kumamoto, Japan). Absorbance was measured at 450 nm using a UV spectrophotometer, and the results were calculated using dilutions of bovine erythrocyte SOD (Sigma) ranging from 0.01–50 units/mL.

Hippocampal catalase activity was analyzed as previously described [30]. The hippocampal homogenates were mixed with phosphate buffer (250 mM, pH 7.0), methanol (12 mM), and H2O2 (44 mM) in sequence. After incubation at RT for 20 min, the reaction was stopped by the addition of Purpald solution (22.8 mM Purpald in 2 N potassium hydroxide). The mixture was incubated at 25 °C for 20 min; then, potassium periodate (65.2 mM in 0.5 N potassium hydrate) was added. Absorbance at 550 nm was measured using a UV spectrophotometer, and the results were calculated using a catalase standard curve.

Determination of total glutathione (GSH) content and glutathione S-transferase (GST) activity

Total GSH contents in the hippocampus were determined as previously described [31]. Hippocampal homogenates were combined with an NADPH (0.3 mM)/DTNB (4 mM) mixture (7:1). Then, a glutathione reductase (GSH-Rd) solution (0.06 units) was added. Absorbance at 405 nm was measured using a UV spectrophotometer, and the GSH contents were calculated using a reduced glutathione standard curve.

The hippocampal GST activity was determined using a commercial assay kit (GST Assay Kit, Sigma). Absorbance at 340 nm was measured using a UV spectrophotometer (Molecular Devices). Enzyme activity was calculated using the following formula: Enzyme activity (unit/mL) = [(∆A340)/min × 0.2 × dilution factor]/(5.3 mM−1 cm−1 × volume of enzyme sample tested).

Immunofluorescent staining and western blot analysis in BV2 cell line

BV2 murine microglial cells were cultured DMEM supplemented with 10% FBS and 1% penicillin-streptomycin at 37 °C in a humidified incubator with 5% CO2. In all experiments, BV2 cells were pre-treated with ALE (1 and 5 μg/mL) or NAC (10 μM) for 3 h before exposure to Gram-negative lipopolysaccharide bacteria (LPS, 1 μg/mL).

For immunofluorescent staining, BV2 cells were plated in 24-well plates at a density of 2 × 105 cells/well for 24 h and washed. Then, the cells were fixed with 4% paraformaldehyde for 10 min, permeabilized with 0.1% Triton X-100 for 10 min, and blocked with 1% bovine serum albumin (BSA) in PBS with Tween 20 (PBST) for 30 min. The cells were incubated in diluted NF-κB p65 antibody in PBST (1:100) for 3 h at RT. After washing, they were incubated with Alexa Fluor® 488-conjugated secondary antibody for 1 h in the dark. The nuclei were counterstained with DAPI solution. Fluorescent images were observed under an Axio-phot microscope (Carl Zeiss).

The cytosolic and nucleic proteins of BV2 cells were separated using NE-PER® Nuclear and Cytoplasmic Extraction Reagents (Thermo scientific) according to the manufacturer’s instruction. Then, western blot analysis was conducted to explore nuclear and cytoplasmic expression of NF-κB p65, and the results were semi-quantified using ImageJ (NIH).

Statistical analysis

All data are expressed as the mean ± standard deviation (SD). Significant differences between groups were evaluated by one-way analysis of variance (ANOVA) followed by post hoc multiple comparisons with Fisher’s LSD t-test using IBM SPSS statistics software, ver. 20.0 (SPSS Inc., Chicago, IL, USA). Differences at P < 0.05 or P < 0.01 were considered significant.

Results

Compositional analysis of ALE

In the fingerprinting analysis of ALE, a total eight of major peaks appeared at 4.84, 5.95, 6.21, 7.26, 7.61, 7.85, 8.83, and 9.20 min of retention time under a UV wavelength of 254 nm (Fig. 1a). The chemical compounds of each peak were identified using high-resolution mass spectrometry. The identified chemical formulae were assumed to be C10H12O3N (ferulamide), C17H18O5N (benzyloxycarbonyl-L-tyrosine), C17H16O4N (Fmoc-L-glycine), C18H20O5N (carbobenzoxy-O-benzyl-L-serine), C18H18O4N (Fmoc-L-alanine or Fmoc-Sarcosine), C17H18O4N (carbobenzyloxy-phenylalanine), C34H33O8N2 or C21H41O19 (unknown), and C18H20O4N (trans-feruloyltyramine), respectively (Fig. 1b).
Fig. 1

Fingerprinting analysis of ALE. ALE was subjected to UHPLC-MS/MS and a chromatogram was obtained at a wavelength of 254 nm (a). The putative chemical structure of each compound was determined using HPLC-MS database (b)

Effects on stress hormones

Repeated restraint stress remarkably increased serum corticosterone and adrenaline levels by 5.2- and 1.6-fold compared with the unstressed group, respectively. ALE treatment significantly reduced the secretion of corticosterone (P < 0.01) and adrenaline (P < 0.05 for only 80 mg/kg group), respectively (Fig. 2a). NAC treatment similarly decreased the serum levels of these stress hormones.
Fig. 2

Stress hormones and oxidative stress biomarkers. Corticosterone and adrenaline levels in the serum (a), ROS levels in both serum and hippocampus (b), and NO (c) and MDA (d) levels in the hippocampus were determined using ELISA. The data are expressed as the means ± SD (n = 7 for hippocampi and = 10 for sera). # P < 0.05 and ## P < 0.01 compared with the unstressed group; * P < 0.05 and ** P < 0.01 compared with the control group

Effects on ROS, NO and MDA levels in hippocampus

In the hippocampus region, repeated restraint stress induced the overproduction of free radicals by 1.4-fold for both total ROS and NO compared with the unstressed group, which was significantly ameliorated by ALE (80 mg/kg) treatment (P < 0.05 for ROS and P < 0.01 for NO, Fig. 2b and c). Lipid peroxidation, measured with MDA level, was notably increased by 1.6-fold in the hippocampus after restraint stress, whereas it was significantly attenuated by ALE treatment when compared with the control group (P < 0.01, Fig. 2d). The stress-induced elevation of serum ROS level was also significantly reduced by ALE treatment (P < 0.05 or <0.01, Fig. 2b), and NAC treatment showed similar effects on hippocampal ROS and MDA levels.

Immunohistochemical analysis in the hippocampus

Repeated restraint stress activated the hippocampal microglial cells and astrocytes, as evidenced by striking elevations of Iba1 and GFAP signals in the cornu ammonis 3 (CA3) region of hippocampus compared with the unstressed group (Fig. 3a and b). These activations were considerably and significantly attenuated by ALE treatment when compared with the control group in quantitative analyses on positive cells (P < 0.01 for both, Fig. 3c). NAC treatment also showed similar effects on these activations.
Fig. 3

Immunohistochemical findings. Iba1-positive microglial cells and GFAP-positive astrocytes were stained in the hippocampus. Representative photomicrographs were taken at magnifications of 40× and the CA3 region was magnified at 200× (a, b). Then, the intensity of Iba1- and GFAP-positive staining was quantified (c). The data are expressed as the means ± SD (n = 3). ## P < 0.01 compared with the unstressed group; ** P < 0.01 compared with the control group. CA3; cornu ammonis 3

Effects on TNF-α and IL-1β in the hippocampus

Repeated restraint stress elevated the hippocampal concentration of TNF-α and IL-1β by 1.9-fold and 1.4-fold compared with the unstressed group, which was significantly ameliorated by ALE treatment (P < 0.01 for TNF-α and P < 0.01 for IL-1β in only 80 mg/kg group, Fig. 4a and b). NAC treatment also significantly reduced the elevations of these cytokines.
Fig. 4

Pro-inflammatory cytokine levels and western blot analyses in the hippocampus. TNF-α and IL-1β levels in the hippocampus were determined using ELISA (a, b). 4-HNE-modified protein, NOX2, iNOS and Nrf2 concentrations in the hippocampus were determined by western blotting (c). Then, the intensities of 4-HNE, NOX2, iNOS and Nrf2 protein expression were quantified (d). The data are expressed as the means ± SD (n = 7). ## P < 0.01 compared with the unstressed group; * P < 0.05 and ** P < 0.01 compared with the control group

Western blot analysis in the hippocampus

Repeated restraint stress dramatically activated the hippocampal 4-HNE-modified protein, NOX2 and iNOS but reduced the Nrf2 protein quantities in the hippocampus, which was significantly alleviated by ALE (80 mg/kg) treatment compared with the control group (P < 0.01 for 4-HNE, NOX2, iNOS and Nrf2, Fig. 4c and d). NAC treatment notably attenuated the expression of 4-HNE and iNOS in the hippocampus.

Effects on antioxidants in the hippocampus

Repeated restraint stress exhausted hippocampal antioxidants, especially GSH (0.7-fold) and catalase (0.6-fold) in the hippocampus when compared with the unstressed group. These alterations were significantly restored by ALE treatment (P < 0.05 or <0.01 for GSH and P < 0.05 for catalase; Fig. 5b and c). The hippocampal SOD and GST levels were not significantly reduced following repeated restraint stress. However, the GST levels were significantly increased by ALE treatment (P < 0.05 or <0.01, Fig. 5a and d). NAC treatment did not show any significant changes in the above biomarkers.
Fig. 5

Antioxidants in the hippocampus. SOD (a), catalase (b), GSH (c), and GST (d) levels in the hippocampus were determined using ELISA. The data are expressed as the means ± SD (n = 7). # P < 0.05, ## P < 0.01 compared with the unstressed group; * P < 0.05, ** P < 0.01 compared with the control group

Effects on NF-κB activation in BV2 microglial cell

LPS (1 μg/mL) treatment activated microglial NF-κB, resulting in translocation of p65 subunit to the nucleus. ALE (5 μg/mL) pre-treatment, however, dramatically inhibited NF-κB p65 nuclear translocation (Fig. 6a). Western blot analysis of the cytoplasmic and nuclear extracts also supported the immunofluorescence data. LPS stimulation resulted in 0.6-fold decrease and 2.3-fold increase in cytosolic and nucleic p65 levels, respectively, which was significantly normalized by ALE treatment (P < 0.01 for both, Fig. 6b and c). NAC, however, did not regulate NF-κB activation by LPS.
Fig. 6

NF-kappa B (NF-κB) activation in lipopolysaccharide (LPS)-treated BV2 microglial cells. Cells were pre-treated with vehicle, ALE (1 and 5 μg/mL) or NAC (10 μM) for 3 h before 1 h exposure to LPS (1 μg/mL). Immunofluroscent staining shows the cellular distribution of NF-κB p65 subunit (green) in microglia. The nuclei were counterstained with DAPI (blue) (a). The p65 expressions in cytosolic and nucleic extracts, respectively, were determined by western blot and semi-quantified using Image J (b, c). The data are obtained from three independent experiments and expressed as the means ± SD (n = 3). ## P < 0.01 compared with control group; * P < 0.05, ** P < 0.01 compared with LPS group

Discussion

Under uncontrolled chronic stress, the negative feedback system of the HPA axis becomes disrupted, resulting in a prolonged activation of the HPA axis [32]. The brain is the main target of excessive stress, which develops stress-related psychiatric disorders and cognitive dysfunction [33, 34]. In particular, hippocampus, amygdala, and prefrontal cortex tissues are susceptible to long-term stress and undergo functional or structural remodeling in response [35, 36]. One recent study showed that restraint stress induced morphological changes in the blood brain barrier, supporting the linkage of stress to neurodegenerative disorders [37]. To investigate the pharmaceutical potential of A. Lignum for anti-oxidative protection against brain injury by stress, the present study adopted a mouse restraint stress model.

The restraint model is the most commonly employed methodology for the induction of stress in experimental animals [26]. As expected, repeated restraint stresses for 6 h every 11 day evoked significant elevations of two typical stress hormones, corticosterone and adrenaline, in the serum (Fig. 2a). Glucocorticoids, as lipophilic steroids, can enter the blood-brain barrier and bind to either of the two types of receptors: high-affinity mineralocorticoid receptors or low-affinity glucocorticoid receptors [38]. Contrary to mineralocorticoid receptors, the glucocorticoid receptors are activated to a larger extent when glucocorticoid levels rise under chronic stress [39, 40]. High concentrations of glucocorticoid are known to trigger mitochondrial dysfunction, cellular apoptosis, synaptic alterations, neuroinflammatory processes, and epigenetic changes in brain [4144].

Among various brain regions, the hippocampus plays key roles in short- and long-term memory and is highly susceptible to oxidative stress [45, 46]. Many clinical studies observed degenerative changes in the hippocampal region of patients with learning and memory deficits such as Alzheimer’s disease [47, 48]. The hippocampus contains glucocorticoid receptors in high proportions [49]. Moreover, corticosterone is known to accelerate ROS formation in brain tissue via mitochondrial activation, which is further aggravated by adrenaline and noradrenaline actions [50, 51]. Additionally, chronic stress promotes NO overproduction in the brain and can suppress hippocampal neurogenesis [52, 53]. In our results, ALE treatment showed anti-oxidative brain injury effects by significantly attenuating the elevation of serum corticosterone and adrenaline levels and oxidative stress parameters, including ROS, NO, and MDA (Fig. 2b–d). These conclusions were partially supported by data measuring antioxidant components, including GSH, GST, and catalase (Fig. 5b–d) and western blot analyses for 4-HNE, iNOS and Nrf2 in the hippocampus (Fig. 4c). These results indicate that ALE protects the hippocampus from stress-induced oxidative alteration.

Brain tissue is prone to oxidative stress due to its compositional and functional features, such as excessive consumption of oxygen [54]. Furthermore, oxidative stress is a potent risk factor in brain ageing and neurodegenerative disorders [55, 56]. Interestingly, many animal studies found that phagocytic NOX2 isoform mediates brain oxidative injury by chronic stress and contributes to behavioral alterations, including anxiety- and depression-like behaviors [8, 57, 58]. The hippocampal region especially showed vulnerability to NOX-derived ROS [9]. In our study, repeated restraint stress notably activated hippocampal NOX2 expression, which was significantly ameliorated by ALE (80 mg/kg) treatment (Fig. 4c and d). The involvement of NOX2 in hippocampal oxidative stress is also partially supported by our histopathological findings showing the significant activation of microglial cells, i.e., the resident immune cells of the central nervous system in the hippocampus (Fig. 3a).

Neuroinflammation is one of the main mechanisms in stress-related brain disorders and is closely linked to oxidative stress [15, 59]. Under chronic stress, microglia cells become substantially activated and release nitric oxide and pro-inflammatory cytokines, including TNF-α and IL-1β [60, 61]. One study demonstrated that the hippocampal CA3 region is one of the most stress-responsive areas with significant microglial alterations [62]. NOX2-derived ROS also plays a role in astrogliosis, which indicates NOX2 and oxidative by-products to be critical factors for glial cell activation and pro-inflammatory cytokine release [63]. As expected, repeated restraint stress drastically activated both microglia and astrocytes, showing ramified cellular processes in the hippocampus, especially in the CA3 region (Fig. 3). However, administration with ALE significantly suppressed neuroglial cell activation and led to a dramatic decrease in pro-inflammatory cytokines, including TNF-α and IL-1β (Fig. 4a and b). Meanwhile, NF-κB is a main transcriptional factor for production of pro-inflammatory cytokines [64]. One main hypothesis formulates psychological stress induces inflammatory responses via Toll-like receptor 4 activation, similar to infection process [65]. In this study, we treated BV2 microglial cell line with LPS to simulate neuroinflammatory state. Interestingly, ALE pre-treatment significantly blocked NF-κB p65 translocation to the nucleus (Fig. 6), which accounts for ALE’s anti-inflammatory effects in the brain exposed to repeated stress. These results suggest that ALE could regulate the production of free radicals and pro-inflammatory cytokines via modulating microglial and astrocytic activation, and NF-κB signaling pathway.

A. Lignum is fragrant resinous heartwood of the Aquilaria species (family Thymelaeaceae) mainly found in Southeast Asian tropical regions [66]. For a long time, Asians have considered the plant as a priceless natural product with anxiolytic, sedative, and anti-inflammatory effects [67]. Recently, various Aquilaria species have been scientifically shown to possess anti-oxidative, anti-inflammatory, and anxiolytic properties [25, 68, 69]. Our preliminary in vitro study also revealed that ALE significantly decreased ROS and LDH activities, which corresponds with its anti-oxidative effect in the current data. The active compounds responsible for the pharmaceutical actions of A. Lignum have not been fully elucidated yet. According to one study, trans-feruloyltyramine, one compound of A. Lignum, significantly attenuates β-amyloid peptide-induced neurotoxicity by reducing ROS and deactivating apoptotic cell death [70]. Studies for identifying its main active compounds will be conducted in the future.

To our knowledge, this study is one of the first to report the efficacy of A. Lignum on preventing repeated restraint stress-induced hippocampal oxidative stress. The activity of 30% ethanol extract of A. Lignum (80 mg/kg) was generally similar or superior to 100 mg/kg of NAC, an amino acid precursor to GSH. Interestingly, NAC treatment notably inactivated iNOS but failed to up-regulate hippocampal Nrf2, a key transcription factor for antioxidants (Fig. 4c). We speculate such factors led to NAC’s inconsistent anti-oxidative effect.

In further studies, we need to verify active single compound of A. Lignum using liquid chromatographic fractionation and its action mechanisms, especially regarding the passage through the blood-brain barrier.

Conclusion

A. Lignum exhibits protective properties against hippocampal oxidative and inflammatory alterations under chronic stress. Its putative corresponding mechanisms involve the modulation in ROS and pro-inflammatory cytokines by microglial cells, and the release of stress hormones.

Abbreviations

ANOVA: 

Analysis of variance

GSH: 

Glutathione

GST: 

Glutathione S-transferase

HNE: 

Hydroxynonenal

IL: 

Interleukin

INOS: 

Inducible nitric oxide synthase

LPS: 

Lipopolysaccharides

MDA: 

Malondialdehyde

MS: 

Mass spectrometry

NF-κB: 

Nuclear factor kappa B

NO: 

Nitric oxide

NOX: 

NADPH oxidase

Nrf: 

Nuclear factor (erythroid-derived 2)-like

RIPA: 

Radioimmunoprecipitation assay

ROS: 

Reactive oxygen species

SOD: 

Superoxide dismutase

TNF: 

Tumor necrosis factor

UHPLC: 

Ultra-high performance liquid chromatography

Declarations

Acknowledgments

Not Applicable.

Funding

This research was supported by the National Research Foundation of Korea (NRF) and funded by the Ministry of Science, ICT and Future Planning (grant number: 2,015,003,195), and by the Daejeon University fund (2015).

Availability of data and materials

All data generated or analysed during this study are included in this published article.

Authors’ contributions

HY Lee and JS Lee wrote the main manuscript text, and conducted experiments. HG Kim prepared the fingerprinting results (UHPLC analysis). WY Kim supported the experiments. SB Lee executed statistical analysis. YH Choi supported NF-κB p65 immunofluorescent staining in BV2 microglial cell line. CG Son supervised the manuscript, and directed final version of all contents. All authors reviewed and approved this manuscript.

Ethics approval

The study was approved from the Institutional Animal Care and Use Committee (IACUC) of Daejeon University (DJUARB2016–029).

Consent for publication

Not Applicable.

Competing interests

The authors declare that they have no competing interests. All of the authors approved the final article.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
College of Korean Medicine, Daejeon University
(2)
Liver and Immunology Research Center, Institute of Traditional Medicine and Bioscience of Daejeon University
(3)
Department of Biochemistry, College of Korean Medicine, Dong-Eui University

References

  1. Goldstein DS, Kopin IJ. Evolution of concepts of stress. Stress. 2007;10(2):109–20.View ArticlePubMedGoogle Scholar
  2. Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci. 2009;10(6):397–409.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Brotman DJ, Golden SH, Wittstein IS. The cardiovascular toll of stress. Lancet. 2007;370(9522):1089–100.View ArticlePubMedGoogle Scholar
  4. Feng Z, Liu L, Zhang C, Zheng T, Wang J, Lin M, et al. Chronic restraint stress attenuates p53 function and promotes tumorigenesis. Proc Natl Acad Sci U S A. 2012;109(18):7013–8.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Jeong YH, Park CH, Yoo J, Shin KY, Ahn SM, Kim HS, et al. Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer’s disease model. FASEB J. 2006;20(6):729–31.PubMedGoogle Scholar
  6. Fontella FU, Siqueira IR, Vasconcellos APS, Tabajara AS, Netto CA, Dalmaz C. Repeated restraint stress induces oxidative damage in rat hippocampus. Neurochem Res. 2005;30(1):105–11.View ArticlePubMedGoogle Scholar
  7. Lucca G, Comim CM, Valvassori SS, Réus GZ, Vuolo F, Petronilho F, et al. Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochem Int. 2009;54(5–6):358–62.View ArticlePubMedGoogle Scholar
  8. Seo JS, Park JY, Choi J, Kim TK, Shin JH, Lee JK, et al. NADPH oxidase mediates depressive behavior induced by chronic stress in mice. J Neurosci. 2012;32(28):9690–9.View ArticlePubMedGoogle Scholar
  9. You JM, Yun SJ, Nam KN, Kang C, Won R, Lee EH. Mechanism of glucocorticoid-induced oxidative stress in rat hippocampal slice cultures. Can J Physiol Pharmacol. 2009;87(6):440–7.View ArticlePubMedGoogle Scholar
  10. Erecińska M, Silver IA. Tissue oxygen tension and brain sensitivity to hypoxia. Respir Physiol. 2001;128(3):263–76.View ArticlePubMedGoogle Scholar
  11. Liu J, Yeo HC, Overvik-Douki E, Hagen T, Doniger SJ, Chyu DW, et al. Chronically and acutely exercised rats: biomarkers of oxidative stress and endogenous antioxidants. J Appl Physiol. 2000;89(1):21–8.PubMedGoogle Scholar
  12. Schafer FQ, Qian SY, Buettner GR. Iron and free radical oxidations in cell membranes. Cell Mol Biol. 2000;46(3):657–62.PubMedPubMed CentralGoogle Scholar
  13. Derijk RH, de Kloet ER. Corticosteroid receptor polymorphisms: determinants of vulnerability and resilience. Eur J Pharmacol. 2008;583(2–3):303–11.View ArticlePubMedGoogle Scholar
  14. Wang Q, Van Heerikhuize J, Aronica E, Kawata M, Seress L, Joels M, et al. Glucocorticoid receptor protein expression in human hippocampus; stability with age. Neurobiol Aging. 2013;34(6):1662–73.View ArticlePubMedGoogle Scholar
  15. Patki G, Solanki N, Atrooz F, Allam F, Salim S. Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress. Brain Res. 2013;1539:73–86.View ArticlePubMedPubMed CentralGoogle Scholar
  16. Sato H, Takahashi T, Sumitani K, Takatsu H, Urano S. Glucocorticoid generates ROS to induce oxidative injury in the hippocampus, leading to impairment of cognitive function of rats. J Clin Biochem Nutr. 2010;47(3):224–32.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Bhattacharya A, Ghosal S, Bhattacharya SK. Anti-oxidant effect of Withania Somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. J Ethnopharmacol. 2001;74(1):1–6.View ArticlePubMedGoogle Scholar
  18. El-Sherbiny DA, Khalifa AE, Attia AS, Eldenshary E-D. Hypericum Perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol Biochem Behav. 2003;76(3–4):525–33.View ArticlePubMedGoogle Scholar
  19. Konishi T. Brain oxidative stress as basic target of antioxidant traditional oriental medicines. Neurochem Res. 2009;34(4):711–6.View ArticlePubMedGoogle Scholar
  20. Alam J, Mujahid M, Badr B, Rahman MA, Akhtar J, Khalid M, et al. An insight of pharmacognostic study and phytopharmacology of Aquilaria Agallocha. J App Pharm Sci. 2015;5(8):173–81.View ArticleGoogle Scholar
  21. Nguyen TTT, Nguyen VD. Biodiversity of major bacterial groups in association with agarwood (Aquilaria Crassna) in Khanh Hoa province. Vietnam J Viet Env. 2014;6(2):132–7.Google Scholar
  22. Dahham SS, Tabana YM, Iqbal MA, Ahamed MBK, Ezzat MO, Majid AS, et al. The anticancer, antioxidant and antimicrobial properties of the Sesquiterpene β-Caryophyllene from the essential oil of Aquilaria Crassna. Molecules. 2015;20(7):11808–29.View ArticlePubMedGoogle Scholar
  23. Okugawa H, Ueda R, Matsumoto K, Kawanishi K, Kato A. Effect of jinkoh-eremol and agarospirol from agarwood on the central nervous system in mice. Planta Med. 1996;62(1):2–6.View ArticlePubMedGoogle Scholar
  24. Wang SL, Hwang TL, Chung MI, Sung PJ, Shu CW, Cheng MJ, et al. New flavones, a 2-(2-Phenylethyl)-4H-chromen-4-one derivative, and anti-inflammatory constituents from the stem barks of Aquilaria Sinensis. Molecules. 2015;20(11):20912–25.View ArticlePubMedGoogle Scholar
  25. Zhang Y, Wang W, Zhang J. Effects of novel anxiolytic 4-butyl-alpha-agarofuran on levels of monoamine neurotransmitters in rats. Eur J Pharmacol. 2004;504(1–2):39–44.View ArticlePubMedGoogle Scholar
  26. Buynitsky T, Mostofsky DI. Restraint stress in biobehavioral research: recent developments. Neurosci Biobehav Rev. 2009;33(7):1089–98.View ArticlePubMedGoogle Scholar
  27. Hayashi I, Morishita Y, Imai K, Nakamura M, Nakachi K, Hayashi T. High-throughput spectrophotometric assay of reactive oxygen species in serum. Mutat Res. 2007;631(1):55–61.View ArticlePubMedGoogle Scholar
  28. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982;126(1):131–8.View ArticlePubMedGoogle Scholar
  29. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978;86(1):271–8.View ArticlePubMedGoogle Scholar
  30. Wheeler CR, Salzman JA, Elsayed NM, Omaye ST, Korte DW. Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Anal Biochem. 1990;184(2):193–9.View ArticlePubMedGoogle Scholar
  31. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70–7.View ArticlePubMedGoogle Scholar
  32. Mizoguchi K, Yuzurihara M, Ishige A, Sasaki H, Chui DH, Tabira T. Chronic stress differentially regulates glucocorticoid negative feedback response in rats. Psychoneuroendocrinology. 2001;26(5):443–59.View ArticlePubMedGoogle Scholar
  33. Gregus A, Wintink AJ, Davis AC, Kalynchuk LE. Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats. Behav Brain Res. 2005;156(1):105–14.View ArticlePubMedGoogle Scholar
  34. Wright RL, Lightner EN, Harman JS, Meijer OC, Conrad CD. Attenuating corticosterone levels on the day of memory assessment prevents chronic stress-induced impairments in spatial memory. Eur J Neurosci. 2006;24(2):595–605.View ArticlePubMedPubMed CentralGoogle Scholar
  35. McEwen BS, Nasca C, Gray JD. Stress effects on neuronal structure: hippocampus, Amygdala, and prefrontal cortex. Neuropsychopharmacology. 2016;41(1):3–23.View ArticlePubMedGoogle Scholar
  36. Mizoguchi K, Ishige A, Aburada M, Tabira T. Chronic stress attenuates glucocorticoid negative feedback: involvement of the prefrontal cortex and hippocampus. Neuroscience. 2003;119(3):887–97.View ArticlePubMedGoogle Scholar
  37. Sántha P, Veszelka S, Hoyk Z, Mészáros M, Walter FR, Tóth AE, et al. Restraint stress-induced morphological changes at the blood-brain barrier in adult rats. Front Mol Neurosci. 2016;8:88.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Joëls M. Functional actions of corticosteroids in the hippocampus. Eur J Pharmacol. 2008;583(2–3):312–21.View ArticlePubMedGoogle Scholar
  39. Dickens M, Romero LM, Cyr NE, Dunn IC, Meddle SL. Chronic stress alters glucocorticoid receptor and mineralocorticoid receptor mRNA expression in the European starling (Sturnus Vulgaris) brain. J Neuroendocrinol. 2009;21(10):832–40.View ArticlePubMedGoogle Scholar
  40. Pariante CM, Miller AH. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry. 2001;49(5):391–404.View ArticlePubMedGoogle Scholar
  41. Adzic M, Djordjevic A, Demonacos C, Krstic-Demonacos M, Radojcic MB. The role of phosphorylated glucocorticoid receptor in mitochondrial functions and apoptotic signalling in brain tissue of stressed Wistar rats. Int J Biochem Cell Biol. 2009;41(11):2181–8.View ArticlePubMedPubMed CentralGoogle Scholar
  42. Krugers HJ, Goltstein PM, van der Linden S, Joëls M. Blockade of glucocorticoid receptors rapidly restores hippocampal CA1 synaptic plasticity after exposure to chronic stress. Eur J Neurosci. 2006;23(11):3051–5.View ArticlePubMedGoogle Scholar
  43. Miller GE, Chen E, Sze J, Marin T, Arevalo JM, Doll R, et al. A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol Psychiatry. 2008;64(4):266–72.View ArticlePubMedPubMed CentralGoogle Scholar
  44. Numakawa T, Kumamaru E, Adachi N, Yagasaki Y, Izumi A, Kunugi H. Glucocorticoid receptor interaction with TrkB promotes BDNF-triggered PLC-gamma signaling for glutamate release via a glutamate transporter. Proc Natl Acad Sci U S A. 2009;106(2):647–52.View ArticlePubMedPubMed CentralGoogle Scholar
  45. Venkateshappa C, Harish G, Mahadevan A, Srinivas Bharath MM, Shankar SK. Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: implications for neurodegeneration in Alzheimer’s disease. Neurochem Res. 2012;37(8):1601–14.View ArticlePubMedGoogle Scholar
  46. Wang X, Pal R, Chen XW, Limpeanchob N, Kumar KN, Michaelis EK. High intrinsic oxidative stress may underlie selective vulnerability of the hippocampal CA1 region. Brain Res Mol Brain Res. 2005;140(1–2):120–6.View ArticlePubMedGoogle Scholar
  47. Becker JT, Davis SW, Hayashi KM, Meltzer CC, Toga AW, Lopez OL, et al. Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment. Arch Neurol. 2006;63(1):97–101.View ArticlePubMedGoogle Scholar
  48. Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, et al. Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer’s disease, mild cognitive impairment, and elderly controls. NeuroImage. 2009;45(1 Suppl):S3–15.View ArticlePubMedGoogle Scholar
  49. Mayer JL, Klumpers L, Maslam S, de Kloet ER, Joëls M, Lucassen PJ. Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis. J Neuroendocrinol. 2006;18(8):629–31.View ArticlePubMedGoogle Scholar
  50. Du J, Wang Y, Hunter R, Wei Y, Blumenthal R, Falke C, et al. Dynamic regulation of mitochondrial function by glucocorticoids. Proc Natl Acad Sci U S A. 2009;106(9):3543–8.View ArticlePubMedPubMed CentralGoogle Scholar
  51. Fu W, Luo H, Parthasarathy S, Mattson MP. Catecholamines potentiate amyloid beta-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis. Neurobiol Dis. 1998;5(4):229–43.View ArticlePubMedGoogle Scholar
  52. Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Fernández AP, Rodrigo J, et al. Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. J Neurochem. 2000;74(2):785–91.View ArticlePubMedGoogle Scholar
  53. Zhou QG, Hu Y, Hua Y, Hu M, Luo CX, Han X, et al. Neuronal nitric oxide synthase contributes to chronic stress-induced depression by suppressing hippocampal neurogenesis. J Neurochem. 2007;103(5):1843–54.View ArticlePubMedGoogle Scholar
  54. Floyd RA, Hensley K. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging. 2002;23(5):795–807.View ArticlePubMedGoogle Scholar
  55. Andersen JK. Oxidative stress in neurodegeneration: cause or consequence? Nat Med. 2004;10(Suppl):S18–25.View ArticlePubMedGoogle Scholar
  56. Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer’s disease. Proc Natl Acad Sci U S A. 2004;101(7):2070–5.View ArticlePubMedPubMed CentralGoogle Scholar
  57. Masood A, Nadeem A, Mustafa SJ, O’Donnell JM. Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. J Pharmacol Exp Ther. 2008;326(2):369–79.View ArticlePubMedPubMed CentralGoogle Scholar
  58. Schiavone S, Jaquet V, Sorce S, Dubois-Dauphin M, Hultqvist M, Bäckdahl L, et al. NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology. Transl Psychiatry. 2012;2:e111.View ArticlePubMedPubMed CentralGoogle Scholar
  59. Wilson CB, McLaughlin LD, Nair A, Ebenezer PJ, Dange R, Francis J. Inflammation and oxidative stress are elevated in the brain, blood, and adrenal glands during the progression of post-traumatic stress disorder in a predator exposure animal model. PLoS One. 2013;8(10):e76146.View ArticlePubMedPubMed CentralGoogle Scholar
  60. Frank MG, Baratta MV, Sprunger DB, Watkins LR, Maier SF. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun. 2007;21(1):47–59.View ArticlePubMedGoogle Scholar
  61. Nair A, Bonneau RH. Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J Neuroimmunol. 2006;171(1–2):72–85.View ArticlePubMedGoogle Scholar
  62. Tynan RJ, Naicker S, Hinwood M, Nalivaiko E, Buller KM, Pow DV, et al. Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav Immun. 2010;24(7):1058–68.View ArticlePubMedGoogle Scholar
  63. Hernandes MS, D’Avila JC, Trevelin SC, Reis PA, Kinjo ER, Lopes LR, et al. The role of Nox2-derived ROS in the development of cognitive impairment after sepsis. J Neuroinflammation. 2014;11:36.View ArticlePubMedPubMed CentralGoogle Scholar
  64. Lawrence T. The nuclear factor NF-κB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651.View ArticlePubMedPubMed CentralGoogle Scholar
  65. Caso JR, Pradillo JM, Hurtado O, Leza JC, Moro MA, Lizasoain I. Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke. Stroke. 2008;39(4):1314–20.View ArticlePubMedGoogle Scholar
  66. Kim KM, Kim IR. A research on the origin of Aquilariae lignum based on its production area and trading status in history. Kor J Herbology. 2011;26(4):163–8.Google Scholar
  67. Hashim YZ, Kerr PG, Abbas P, Mohd SH. Aquilaria spp. (agarwood) as source of health beneficial compounds: a review of traditional use, phytochemistry and pharmacology. J Ethnopharmacol. 2016;189:331–60.View ArticlePubMedGoogle Scholar
  68. Chitre T, Bhutada P, Nandakumar K, Somani R, Miniyar P, Mundhada Y, et al. Analgesic and anti-inflammatory activity of heartwood of Aquilaria Agallocha in laboratory animals. Pharmacol Online. 2007;1:288–98.Google Scholar
  69. Miniyar PB, Chitre TS, Deuskar HJ, Karve SS, Jain KS. Antioxidant activity of ethyl acetate extract of Aquilaria Agallocha on nitrite-induced methaemoglobin formation. Int J Green Pharm. 2008;2(2):116–7.View ArticleGoogle Scholar
  70. Thangnipon W, Suwanna N, Kitiyanant N, Soi-Ampornkul R, Tuchinda P, Munyoo B, et al. Protective role of N-trans-feruloyltyramine against β-amyloid peptide-induced neurotoxicity in rat cultured cortical neurons. Neurosci Lett. 2012;513(2):229–32.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement